The risk of acute disseminated encephalomyelitis (ADEM) following covid-19 vaccination in England: A self-controlled case-series analysis
ABSTRACTAcute disseminated encephalomyelitis (ADEM) has been identified as an Adverse Event of Special Interest in the COVID-19 vaccine programme due to its long-standing temporal association with a wide range of other vaccines. Case reports of ADEM shortly following COVID−19 vaccination have now be...
Główni autorzy: | Julia Stowe, Jamie Lopez-Bernal, Nick Andrews |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
Taylor & Francis Group
2024-12-01
|
Seria: | Human Vaccines & Immunotherapeutics |
Hasła przedmiotowe: | |
Dostęp online: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2311969 |
Podobne zapisy
-
Acute Disseminated Encephalomyelitis: A Review of Eleven Cases in Childhood in North of Iran
od: Ali Nikkhah, i wsp.
Wydane: (2016-01-01) -
An Interesting Case Of Acute Disseminated Encephalomyelitis
od: Satish Kumar, i wsp.
Wydane: (2008-04-01) -
The Epidemiologic and Demographic Characteristics and Clinical Findings in Patients with Acute Disseminated Encephalomyelitis (ADEM) Referred to Alzahra Hospital, Isfahan, Iran, During 10 Years (2003-2013)
od: Masoud Etemadifar, i wsp.
Wydane: (2015-09-01) -
A rare fatal case of adenovirus serotype 4 associated acute disseminated encephalomyelitis in an adult: A case report
od: Zahra Qamar, i wsp.
Wydane: (2021-01-01) -
Whole exome sequencing in a child with acute disseminated encephalomyelitis, optic neuritis, and periodic fever syndrome: a case report
od: Pablo A. Ledesma, i wsp.
Wydane: (2019-12-01)